Showing results (131-140 of 220) with videos related to
Sort By:
Pageof 22
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 1, 1992
Evaluation of new anti-infective drugs for the treatment of toxoplasma encephalitis. Infectious Diseases Society of America and the Food and Drug AdministrationM A Sande, R J Whitley, G H McCracken, et al.Infection and Immunity|August 1, 1983
Susceptibility of brain to aerobic, anaerobic, and fungal organismsG T Costello, R Heppe, H R Winn, et al.The American Journal of Medicine|April 27, 1987
Oral ciprofloxacin therapy for gram-negative bacillary osteomyelitisA J Lesse, C Freer, R A Salata, et al.Antimicrobial Agents and Chemotherapy|April 1, 1981
Moxalactam and cefazolin: comparative pharmacokinetics in normal subjectsW M Scheld, D A Spyker, G R Donowitz, et al.The Journal of Infectious Diseases|October 1, 1983
Treatment of experimental brain abscess with penicillin and chloramphenicolE C Haley, G T Costello, G T Rodeheaver, et al.Antimicrobial Agents and Chemotherapy|February 1, 1982
Pharmacokinetics of cefaclor in renal failure: effects of multiple doses and hemodialysisD A Spyker, L L Gober, W M Scheld, et al.Kidney International|September 1, 1984
Effect of hemodialysis and peritoneal dialysis on aztreonam pharmacokineticsJ S Gerig, N D Bolton, E A Swabb, et al.Antimicrobial Agents and Chemotherapy|December 1, 1980
Pharmacokinetics of moxalactam in subjects with various degrees of renal dysfunctionW K Bolton, W M Scheld, D A Spyker, et al.Journal of Clinical Epidemiology|February 1, 1992
Reliability of a measure of severity of illness: acute physiology of chronic health evaluation--IIA M Damiano, M Bergner, E A Draper, et al.Pageof 22